Napo Pharmaceuticals
Crofelemer
A proprietary gastro-intestinal compound in clinical development for four distinct product indications
 |
 |
 |
|
||
 |
|
 |
|
||
news
May 3, 2012
Napo Comments on FDA Announcing Extension
of Crofelemer NDA Priority Review
Napo Comments on FDA Announcing Extension of Crofelemer NDA Priority Review
March 8, 2012
New Treatment Presented for Chronic Diarrhea in HIV/AIDS Patients
New Treatment Presented for Chronic Diarrhea in HIV/AIDS Patients
February 8, 2012
FDA Grants PDUFA Date of June 5, 2012 for Crofelemer
FDA Grants PDUFA Date of June 5, 2012 for Crofelemer
January 11, 2012
Napo Secures Dismissal of Legal Action.pdf
Napo Secures Dismissal of Legal Action.pdf
If you would like to receive e-mail alerts when we send out press releases, please send an e-mail to news@napopharma.com with the subject 'subscribe'.
